KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell lymphoma including through use in the community setting ...

Title: CRISPR/Cas-mediated APOC3 Knockout as a One-time Treatment for Severe Hypertriglyceridemia Presenters: Alan Brooks, PhD, Senior Vice President of Research at Metagenomi Date/time: Monday, ...

This week, Svante Pääbo, Nobel Prize winner for sequencing the Neanderthal genome, is visiting Estonia. In an interview with ...

The big biotech, which has made genetic medicine a focus in recent years, is paying Tessera $150 million for rights to a ...